Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical study

Shingrix reduces cardiovascular disease risk

Analysis based on 29 articles · First reported Aug 26, 2026 · Last updated Aug 29, 2026

Sentiment
60
Attention
4
Articles
29
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The study could boost demand for Zoster vaccine, benefiting its manufacturer, and may influence vaccination policies for older adults. If confirmed, it could reduce healthcare costs and improve public health, but the observational nature limits immediate market impact.

Pharmaceuticals Healthcare Biotechnology

A study led by Maxime Taquet at the University of Oxford, published in Nature Medicine, analyzed health records of over 70,000 US adults aged 60 and older from the TriNetX database. The study leveraged the 2017 switch from the Zoster vaccine to the Zoster vaccine shingles vaccine in the United States as a natural experiment. It found that recipients of Zoster vaccine had a 12% lower risk of cardiovascular events (heart attack, stroke, heart failure) in the first 3.5 years after vaccination, with a 9% longer time without cardiovascular disease over seven years. The protective effect was strongest for ischemic heart disease and heart failure, and was significant in men for ischemic stroke. The benefit waned over time but remained. The mechanism is unclear but may involve reduced inflammation or better shingles prevention. The findings are observational and require confirmation by randomized controlled trials, including an ongoing trial in Denmark. If confirmed, Zoster vaccine could prevent hundreds of thousands of cardiovascular cases and be comparable to antihypertensive medication. The United Kingdom — National Health Service in the United Kingdom offers Zoster vaccine to older adults. Experts including John Tregoning, Betty Raman, Paul Harrison, and Hugo Pedder commented on the study.

80 Maxime Taquet led study
70 United States switched vaccines
70 Paul Harrison co-led study
60 Denmark conducting trial
50 Fabiana Corsi-Zuelli co-authored study
50 Betty Raman co-authored study
per
Lead researcher who presented the findings and highlighted potential public health impact.
Importance 90.0 Sentiment 60.0
oth
The older vaccine used as comparator; its replacement by Zoster vaccine enabled the natural experiment.
Importance 70.0 Sentiment -20.0
cnt
The setting of the study; potential policy implications for vaccination recommendations.
Importance 60.0 Sentiment 40.0
govactor
Offers Zoster vaccine to eligible populations; findings may support broader vaccination programs.
Importance 50.0 Sentiment 40.0
cnt
NHS offers Zoster vaccine; findings may influence UK vaccination policy.
Importance 40.0 Sentiment 40.0
priv
Provided the electronic health records data used in the study.
Importance 40.0 Sentiment 20.0
per
Co-authored the study, contributing to the analysis of immune mechanisms.
Importance 30.0 Sentiment 50.0
cnt
Hosting a randomized trial that could confirm the findings.
Importance 30.0 Sentiment 30.0
per
Provided expert commentary supporting the vaccine's benefits.
Importance 20.0 Sentiment 10.0
per
Co-author who discussed potential mechanisms involving immune reprogramming.
Importance 20.0 Sentiment 10.0
per
Provided commentary on possible mechanisms linking the vaccine to heart health.
Importance 20.0 Sentiment 10.0
per
Provided independent commentary, explaining possible mechanisms.
Importance 15.0 Sentiment 40.0
per
Provided independent commentary, highlighting population-level implications.
Importance 15.0 Sentiment 40.0
per
Provided independent commentary, noting the study addresses a key question.
Importance 15.0 Sentiment 40.0
per
External researcher who commented on the need for randomized trials.
Importance 15.0 Sentiment 5.0
United States allies ↔ United Kingdom The United States considers the United Kingdom a vital defense ally and significant economic partner, relying on its str
United States related ↔ Denmark
United Kingdom related ↔ Denmark
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.